ArticleLeukemia2008
Mesenchymal stem cells for graft-versus-host disease: a double edged sword?
Article in Leukemia, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy.Experimental hematology & oncology · 2025Review
- Preliminary high-dose irradiation of the recipient and associated damage of bone marrow stromal compartment enables bone marrow stroma transplantation.Scientific reports · 2025Article
- Advances and clinical challenges of mesenchymal stem cell therapy.Frontiers in immunology · 2024Review
- Stromal cells in the tumor microenvironment: accomplices of tumor progression?Cell death & disease · 2023Review
- Mesenchymal stem/stromal cells in cancer therapy.Journal of hematology & oncology · 2021Review
- Mesenchymal stem cell-based therapy for autoimmune diseases: emerging roles of extracellular vesicles.Molecular biology reports · 2019Review
- Role of gamma-secretase in human umbilical-cord derived mesenchymal stem cell mediated suppression of NK cell cytotoxicity.Cell communication and signaling : CCS · 2014Article
- Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2.Stem cells and development · 2014Article
- Mesenchymal stromal cells: a key player in 'innate tolerance'?Immunology · 2012Review
- Phenotypic and functional characterization of human bone marrow stromal cells in hollow-fibre bioreactors.Journal of tissue engineering and regenerative medicine · 2012Article
- Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells.Journal of biomedical science · 2011Review
- Immunomodulatory properties and therapeutic application of mesenchymal stem cells.Clinical and experimental immunology · 2011Review
- Mesenchymal stem cells in the pathogenesis and therapy of breast cancer.Journal of mammary gland biology and neoplasia · 2010Review
- Mesenchymal stem cells as therapeutics.Annual review of biomedical engineering · 2010Review
- Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor.Bone marrow transplantation · 2009Article
- Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor.Bone marrow transplantation · 2009Article
- Article
- Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.Journal of cellular and molecular medicine · 2008Review
- Innovative approaches to treat steroid-resistant or steroid refractory GVHD.Bone marrow transplantation · 2008Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
18335000What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.